Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508607 · ClinicalTrials.gov registry record
Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 13,319
- Enrollment target
NCT05508607 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 13,319 participants.
The verdict
NCT05508607 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 13,319 participants
- Enrollment target
Study Summary
To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
Interventions
- OTHER CDI-risk Classification Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,319 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05508607
The ClinicalTrials.gov registry entry for NCT05508607 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CDI-risk Classification Tool is the first listed.
NCT05508607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05508607 about?
NCT05508607 is a clinical study titled "Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention". To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
What is the current status of trial NCT05508607?
This trial is currently completed. The enrollment target is 13,319 participants. The study started on 2021-05-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05508607?
The interventions under investigation include: CDI-risk Classification Tool (OTHER).
Who is sponsoring clinical trial NCT05508607?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.